Skip to main content

Young Caroline's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed Apr 4, 2025

Accession no.
0001628280-25-016745
Filed
Apr 4, 2025
Trade date
Mar 3-31, 2025
Filing delay
32 daysLate
Rule 10b5-1 plan
Checked

This filing lists 21 non-derivative transactions and 0 derivative transactions. Open-market purchases total $383.66. It was filed 32 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Young CarolineCIK 0001684087Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 3, 2025Common StockPPurchaseAcquired+4$5.54+$22.1632,322Direct
Mar 4, 2025Common StockPPurchaseAcquired+4$5.11+$20.4432,326Direct
Mar 5, 2025Common StockPPurchaseAcquired+4$6.75+$2732,330Direct
Mar 6, 2025Common StockPPurchaseAcquired+4$6.57+$26.2832,334Direct
Mar 7, 2025Common StockPPurchaseAcquired+4$6.51+$26.0432,338Direct
Mar 10, 2025Common StockPPurchaseAcquired+3$5.85+$17.5532,341Direct
Mar 11, 2025Common StockPPurchaseAcquired+3$4.85+$14.5532,344Direct
Mar 12, 2025Common StockPPurchaseAcquired+3$5.17+$15.5132,347Direct
Mar 13, 2025Common StockPPurchaseAcquired+3$5.47+$16.4132,350Direct
Mar 14, 2025Common StockPPurchaseAcquired+3$5.38+$16.1432,353Direct
Mar 17, 2025Common StockPPurchaseAcquired+3$5.41+$16.2332,356Direct
Mar 18, 2025Common StockPPurchaseAcquired+3$5.12+$15.3632,359Direct
Mar 19, 2025Common StockPPurchaseAcquired+3$5.41+$16.2332,362Direct
Mar 20, 2025Common StockPPurchaseAcquired+3$5.07+$15.2132,365Direct
Mar 21, 2025Common StockPPurchaseAcquired+3$4.89+$14.6732,368Direct
Mar 24, 2025Common StockPPurchaseAcquired+4$4.42+$17.6832,372Direct
Mar 25, 2025Common StockPPurchaseAcquired+4$4.45+$17.832,376Direct
Mar 26, 2025Common StockPPurchaseAcquired+4$4.41+$17.6432,380Direct
Mar 27, 2025Common StockPPurchaseAcquired+4$4.20+$16.832,384Direct
Mar 28, 2025Common StockPPurchaseAcquired+4$4.20+$16.832,388Direct
Mar 31, 2025Common StockPPurchaseAcquired+4$4.29+$17.1632,392Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)